Allahna Esber, Ph.D., became a program officer with MPIDB in 2023. Her research interests include observational and data-driven research to inform policy and HIV delivery systems, particularly in global health settings.
Prior to joining NICHD, Dr. Esber served as a senior epidemiologist with the U.S. Military HIV Research Program, supporting the multi-country African Cohort Study and several Phase I/II HIV vaccine trials. Her work focused on evaluating U.S. President’s Emergency Plan for AIDS Relief care and treatment, specifically on assessing the programmatic rollout of dolutegravir and health implications of persistent low-level viremia. She also supported research on infectious and noninfectious comorbidities, mental health, and family planning among people living with HIV in sub-Saharan Africa.
Dr. Esber earned her B.A. in history from Colgate University in Hamilton, New York; an M.S.P.H. in population, family, and reproductive health from Johns Hopkins Bloomberg School of Public Health; and a Ph.D. in epidemiology from the Ohio State University.